Gene Expression Network Analysis Identifies Potential Targets for Prevention of Preeclampsia

Yu Xia; Yu-Dong Zhao; Gui-Xiang Sun; Shuai-Shuai Xia; Zheng-Wang Yang

doi:10.2147/IJGM.S348175

Gene Expression Network Analysis Identifies Potential Targets for Prevention of Preeclampsia

Int J Gen Med. 2022 Feb 2:15:1023-1032. doi: 10.2147/IJGM.S348175. eCollection 2022.

Authors

Yu Xia^{1

2

3}, Yu-Dong Zhao⁴, Gui-Xiang Sun^{1

2}, Shuai-Shuai Xia¹, Zheng-Wang Yang³

Affiliations

¹ Provincial Key Laboratory of TCM Diagnostics, Hunan University of Chinese Medicine, Changsha, Hunan Province, 410208, People's Republic of China.
² Institute of Chinese Medicine Diagnosis, Hunan University of Chinese Medicine, Changsha, Hunan Province, 410208, People's Republic of China.
³ Department of Obstetrics and Gynecology, The First Hospital of Hunan University of Chinese Medicine, Changsha, Hunan Province, 410007, People's Republic of China.
⁴ School of Clinical Medicine, Chengdu University of Traditional Chinese Medicine, Chengdu, 610075, People's Republic of China.

Abstract

Objective: Preeclampsia (PE) is a pregnancy-specific multisystem disease as well as an important cause of maternal and perinatal death. This study aimed to analyze the placental transcriptional data and clinical information of PE patients available in the published database and predict the target genes for prevention of PE.

Methods: The clinical information and corresponding RNA data of PE patients were downloaded from the GEO database. Cluster analysis was performed to examine the correlation between different genotyping genes and clinical manifestations. Then, bioinformatic approaches including GO, KEGG, WGCNA, and GSEA were employed to functionally characterize candidate target genes involved in pathogenesis of PE.

Results: Two PE datasets GSE60438 and GSE75010 were obtained and combined, thereby providing the data of 205 samples in total (100 non-PE and 105 PE samples). After eliminating the batch effect, we grouped and analyzed the integrated data, and further performed GSEA analysis. It was found that the genes in group 1 and group 2 were different from those in normal samples. Moreover, WGCNA analysis revealed that genes in group 1 were up-regulated in turquoise module, including SASH1, PIK3CB and FLT-1, while genes in group 2 were up-regulated in the blue and brown modules. We further conducted GO and KEGG pathway enrichment analyses and found that the differential genes in turquoise module were mainly involved in biological processes such as small molecular catabolic process, while being highly enriched in pathways, including MAPK signaling pathway and Rap1 signaling pathway.

Conclusion: FLT-1 was conventionally used to predict PE risk, and sFLT-1 could also be used as an indicator to evaluate PE treatment effect. As a candidate biomarker for predicting PE, SASH1 may participate in proliferation, migration, invasion and epithelial mesenchymal transformation of human trophoblast cells by regulating MAPK pathway and Rap1 signaling pathway, thus affecting the progression of PE. The mechanism allowing PIK3CB to regulate PE development was not clear, while the gene could be another candidate biomarker for PE risk prediction. This is an exploratory study and our findings were still required verification in further studies.

Keywords: FLT-1; MAPK signaling pathway; PIK3CB; Rap1 signaling pathway; SASH1; preeclampsia.

Grants and funding

This work was supported by the Special funds for traditional Chinese medicine subsidized by the central government of the State Administration of traditional Chinese Medicine (No. [2015]78).